Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Hematology, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, China.
Front Immunol. 2021 Nov 18;12:724411. doi: 10.3389/fimmu.2021.724411. eCollection 2021.
The expression level of BCMA in bone marrow of 54 MM patients was detected in this study to explore the relationship between the BCMA expression and the classification, stage, and prognostic factors of MM. The BCMA expression level of the stable group and remission group was lower than that of the newly diagnosed group and relapse group (P=0.001). There was no significant difference in BCMA expression of MM patients in different types and stages (P>0.05), but it was found that for the newly diagnosed MM patients, the BCMA expression level of IgG patients was higher than that of IgA or light-chain patients (rank average 11.20 5.44, P=0.014). There was no significant correlation between the BCMA expression and the age and serum creatinine of MM patients (P>0.05). And there was no significant difference in BCMA expression between patients with different levels of age and serum creatinine (P>0.05). But it was found that the BCMA expression level of the newly diagnosed MM patients was moderately positively correlated with their age (P=0.025, r=0.595). There was no significant correlation between the BCMA expression and serum β2-microglobulin, serum lactate dehydrogenase, free kap/lam ratio, and urine β2-microglobulin (P>0.05). But we found that the BCMA expression of patients with high serum β2-microglobulin was higher than that of patients with low serum β2-microglobulin (rank average 28.89 17.54, P=0.017). And the BCMA expression of patients with abnormal serum free kap/lam ratio was higher than that of patients with normal ratio (rank average 28.49 13.55, P=0.004). The BCMA expression was strongly positively correlated with 24-h urine protein, was moderately positively correlated with serum M protein and the percentage of plasma cells in bone marrow, was moderately negatively correlated with albumin and hemoglobin count, and was weakly positively correlated with serum corrected calcium (P<0.05). And it was found that the BCMA expression of positive serum immunofixation electrophoresis patients was higher than that of negative patients (rank average 29.94 16.75, P=0.017). And we try to clarify the relationship between the bone marrow BCMA expression and the peripheral blood sBCMA expression. However, we have not found a clear correlation between them so far (P>0.05).
本研究检测了 54 例 MM 患者骨髓中 BCMA 的表达水平,旨在探讨 BCMA 表达与 MM 患者的分类、分期和预后因素之间的关系。稳定组和缓解组的 BCMA 表达水平低于初诊组和复发组(P=0.001)。不同类型和分期的 MM 患者的 BCMA 表达水平无显著差异(P>0.05),但发现初诊 MM 患者中 IgG 型患者的 BCMA 表达水平高于 IgA 或轻链型患者(秩平均 11.20 5.44,P=0.014)。BCMA 表达与 MM 患者的年龄和血清肌酐无显著相关性(P>0.05)。不同年龄和血清肌酐水平的患者的 BCMA 表达水平无显著差异(P>0.05)。但发现初诊 MM 患者的 BCMA 表达水平与年龄呈中度正相关(P=0.025,r=0.595)。BCMA 表达与血清β2-微球蛋白、血清乳酸脱氢酶、游离 kap/lam 比值和尿β2-微球蛋白无显著相关性(P>0.05)。但我们发现,高血清β2-微球蛋白患者的 BCMA 表达水平高于低血清β2-微球蛋白患者(秩平均 28.89 17.54,P=0.017)。血清游离 kap/lam 比值异常患者的 BCMA 表达水平高于比值正常患者(秩平均 28.49 13.55,P=0.004)。BCMA 表达与 24 小时尿蛋白呈强正相关,与血清 M 蛋白和骨髓浆细胞百分比呈中度正相关,与白蛋白和血红蛋白计数呈中度负相关,与血清校正钙呈弱正相关(P<0.05)。发现血清免疫固定电泳阳性患者的 BCMA 表达水平高于阴性患者(秩平均 29.94 16.75,P=0.017)。我们试图阐明骨髓 BCMA 表达与外周血 sBCMA 表达之间的关系,但到目前为止尚未发现它们之间存在明确的相关性(P>0.05)。